HOXA4 and chronic myelogenous leukemia, BCR-ABL1 positive: When the HOXA4 methylation profile among CML patients showing good response and resistance to IM was evaluated separately, hypermethylation was found to be significantly less dense in IM good response CML patients, compared to IM-resistant CML patients.